Diagnostic driven strategies for antimicrobial resistance in the UK

view the recording here

Thank you for taking the time to view this webinar, we hope you find it informative.

RCPath CPD accredited

Co-presenters: Gail Hayward, Jeff Featherstone, Becky Albrow, Mike Messenger, Aleksandra Borek, Sharon Dixon and Daniel Berman

– – – – –

If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.

Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.

If you have any problems creating or downloading your certificate please contact Esme Carruthers at ecarruthers@bsac.org.uk

Hosted in collaboration with the Longitude Prize, Nesta Challenges

e-Learning course:

Diagnostic driven strategies for antimicrobial resistance in the UK

The aim of this course is to help build an understanding of the NHS commissioning path for AMR diagnostic tests.

Bringing together the perspectives of NHS, England, NICE, the MHRA and clinicians you should get a good understanding of what is important to these groups when delivering an end result test.To access the course please click on the button below.

This will open the log in page in your default browser, all you will need to do is input an email and make a password, then you will be automatically redirected to the course.

If you have any issues with accessing the course, please contact navin@BSAC.org.uk.

Activate course link
By ticking this box and accessing the course you confirm you’re happy for BSAC to send you details of other content we think you’ll like. We’ll never share your details with a third party and you can unsubscribe at any time.


Professor Gail Hayward, Associate Professor of Primary Care, University of Oxford & Deputy Director, NIHR Community Healthcare MIC

Professor Gail Hayward is a GP and clinical researcher interested in improving the diagnosis and management of infectious diseases in primary care. She leads the NIHR Community Healthcare MedTech and IVD Cooperative

Dr Aleksandra Borek, Researcher in Behaviour Change, University of Oxford

Aleksandra is a researcher in social and behavioural sciences. Her research focuses on using behavioural approaches to optimising antibiotic prescribing/use and implementation of antimicrobial stewardship interventions (including point-of-care diagnostics) in primary care.

Dr Jeff Featherstone, Head of Antimicrobial Resistance Medical Directorate, NHS England and NHS Improvement

Jeff is Head of AMR in NHS England & Improvement. He brings experience of successfully managing a variety of national programmes that involved supporting evidence-based changes in practice at local level, including diabetes treatment, diabetic eye screening and breast screening. Jeff has worked at national, regional and local levels in the NHS, as well as working in social care and the integrated health and social care system in Northern Ireland. He has particular interests in evidence-based practice and in integrated care.

Daniel Berman , Global Health Director, Nesta Challenges

Daniel leads Global Health at Nesta Challenges and manages the Longitude Prize on AMR, which is a £10 million project to incentivise the development of a rapid diagnostic test to improve the use of antibiotics. In the healthy aging space Nesta Challenges has been collaborating with the UK’s Alzheimer’s Society since November 2019 to develop a Challenge Prize on Dementia.

Previously, Daniel was a consultant for the World Health Organization in Ethiopia. Before that he worked at Médecins Sans Frontières (MSF) for more than 16 years. He is currently a Trustee for QUAMED, a French NGO focused on medicines quality.

Dr Sharon Dixon, General Practitioner & Clinical Researcher University of Oxford

Sharon Dixon is a GP and a qualitative researcher, including primary care perspectives on pathways to care. She has worked on two mixed method evaluations of service improvement projects in out of hours primary care which made new point of care technologies available to clinicians.

Dr Becky Albrow, Technical Advisor, NICE

Rebecca is the interim Associate Director in the NICE Diagnostics Assessment Programme. She has been in the team since 2013, previously working as a Technical Analyst and a Technical Adviser. She joined NICE in 2012, initially working in the Medical Technologies Evaluation Programme.
Rebecca has a Masters of Public Health from the University of Manchester. Prior to joining NICE she spent several years working on NHS NIHR funded research projects investigating the use of new technologies in cervical screening.

Dr Mike Messenger, – Mike Messenger, Principal Scientific Advisor for In Vitro Diagnostics (IVDs) at Medicines and Healthcare products Regulatory Agency (MHRA)

Mike is the Principal Scientific Advisor for IVD’s at the MHRA and a visiting Professor at the University of Leeds. His career to date has spanned a broad range of medical technology industries, from Pharmaceuticals, Advanced Therapies, Medical Devices, In Vitro Diagnostics (IVDs) and more recently Artificial Intelligence. However, the past decade has seen his interest and expertise focus down around the field of medical testing, in particular precision/personalised medicine and health. In his academic roles, he has led or supported teams in the development and evaluation of >35 commercial IVDs, leading to 9 pieces of NICE guidance and advice, with at least 4 IVDs entering into clinical use off the back of our research. He was recently a co-investigator on ~£35M worth of research grants including the Yorkshire Lung Screening Trial and CRUK CanTest collaborative. Furthermore, during his 7 years of National Institute for Health and Care Excellence (NICE) diagnostic advisory committee (DAC) membership, he has been involved in the assessment of >30 diagnostic technologies.

Finally, he has been a scientific advisor to DHSC, NHS England, NIHR i4i Programme, CRUK, MRC and EU Innovative Medicines Initiative (IMI).

Emily Wighton, Head of Programmes for the Chief Scientific Officer, NHS England and NHS Improvement

A Clinical Pharmacist Prescriber by background, Emily has a healthy curiosity and appreciation of people, systems and context when approaching ‘wicked’ problems. Emily specialises in networked learning and clinically-led service (and organisational) development.

Emily is currently Head of Programmes for the Chief Scientific Officer at NHS England and NHS Improvement, having previously been a Senior Programme Lead for Population Health Management (PHM) in the Primary Care and System Transformation (PCST) team and the National Care Homes Senior Manager for the Enhanced Health in Care Homes (EHCH) New Care Models programme. She successfully supported implementation of the Enhanced Health in Care Homes (EHCH) framework by 14 ICS and Devolved sites in England, resulting in the model’s inclusion in the NHS Long Term Plan as an exemplar of integrated care model design. She also provided interim clinical leadership for the Primary Care Network Clinical Pharmacist programme.

She qualified as a pharmacist in 2003, and has experience in acute, primary and community pharmacy practice, education and the voluntary sector, specialising in palliative care. Emily completed her Darzi Fellowship in Healthcare Leadership in July 2017 where she developed an education framework for professionals working with people with diabetes in Lewisham and set up a peer support network for health workers and people with diabetes.